Parallax Volatility Advisers, L.P. Iveric Bio, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $3.76 Million - $5.68 Million	143,300 Added 135.32%	249,200 $9.8 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $1.98 Million - $2.6 Million	105,900 New	105,900 $2.58 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $376,000 - $743,600	40,000 New	40,000 $718,000
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $558,900 - $774,179	46,000 Added 460.0%	56,000 $942,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $70,700 - $175,000	10,000 New	10,000 $162,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.